[Retracted] Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma

Table 1

The results of Cox regression analysis.

Clinicopathologic variable	HR (95% CI)
AGE ≤64
Age	1.02 (0.97–1.08)	0.42
Stage	2.32 (1.49–3.19)	<0.00
Grade	3.48 (1.74–6.95)	<0.00
PARVG	0.44 (0.20–0.95)	0.04
AGE >64
Age	1.04 (1.00–1.09)	0.07
Stage	1.81 (1.41–2.33)	<0.00
Grade	1.86 (1.12–3.11)	0.02
PARVG	0.56 (0.31–1.01)	0.05

Univariate analysis using Cox regression revealed that some factors, including patient age (HR = 1.02, value = 0.42), pathological stage (HR = 2.32, value <0.001), and pathological grade (HR = 3.48, value <0.001) along with the expression of PARVG (HR = 0.794, value <0.046) are significantly associated with overall survival. The upregulated PARVG expression, lower patient age, lower pathological stage, and lower pathological grade are independent prognostic factors of favorable prognosis.